Hepatitis C virus recurrence after liver transplantation: analysis of factors related to sustained viral response.
Jiménez-Pérez
M
M
Unidad de Hepatología-Trasplante Hepático, Servicio de Aparato Digestivo, Málaga, Spain. mjimenezp@commalaga.com
Sáez-Gómez
A B
AB
Pérez-Daga
J A
JA
Lozano-Rey
J M
JM
de la Cruz-Lombardo
J
J
Rodrigo-López
J M
JM
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000453:epidemiology* / Q000235:genetics / Q000601:surgery; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use; D019562:Viral Load
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b